Browsing: Medication & Drugs

Etrasimod: New Treatment Option for Ulcerative Colitis

By Tony ZhangJuly 20, 20230

Zavicefta: Life-Saving Antibiotic for Carbapenemase-Producing Enterobacterales

By Tony ZhangJuly 19, 20230

Opioid Medicine: FDA Updates Prescribing Information and Warnings

By kethleen lohJuly 18, 20230

Pholcodine withdrawn – ALPHO case-control study

By Tony ZhangJuly 17, 20230

Opioids No Better than Placebos in Mitigating Mid-40s Lower Back Pain, Study Finds

By Gerald NgJuly 4, 20230

A team of Australian researchers has found no evidence that opioids are more effective than placebos in managing lower back pain in middle-aged individuals.

Deucravacitinib (Sotyktu): First-In-Class, Allosteric Tyrosine Kinase 2 (Tyk2) Inhibitor For Adults With Moderate-To-Severe Plaque Psoriasis Approved

By Rachel TanJune 29, 20230

A new oral option for moderate-to-severe plaque psoriasis has emerged. Clinical trials show deucravacitinib delivering stronger efficacy than apremilast, offering a fresh approach after nearly a decade without major oral treatment innovation.

Singapore Withdraws Popular Cough Medicine Due To Health Risks

By Gerald NgJune 27, 20230

The Health Sciences Authority (HSA) in Singapore has made a regulatory decision to withdraw pholcodine-containing products from the market. This ban affects the range of cough liquids and lozenges from the brand Duro-Tuss & Difflam.

FDA Approves Omisirge Cell Therapy to Reduce Infection Risk in Patients with Hematologic Malignancies

By kethleen lohJune 6, 20230

Omisirge is used in adults and children aged 12+ for cord blood transplant after myeloablative conditioning in hematologic malignancies.

Beware: FDA Warns Against Non-Branded Alternatives of Ozempic and Wegovy

By Saba KashJune 5, 20230

The FDA warning about non-branded alternatives to Ozempic and Wegovy highlights the risks posed by unregulated options.

Case Study: Filipino on Doxorubicin and Cyclophosphamide Experienced Disturbed Consciousness

By Kit YarnJune 2, 20230

Doxorubicin and Cyclophosphamide is a commonly used combination but their use has rarely led to diagnosis of type 1 diabetes.

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Grateful, But Still Not Free From Haemophilia

How an Automated 3D Breast Ultrasound System Is Changing Imaging Workflows

Prof Poh Kian Keong is Singapore’s Only Recipient of the American College of Cardiology’s 2026 Distinguished Awards

Browsing: Medication & Drugs

Etrasimod: New Treatment Option for Ulcerative Colitis

Zavicefta: Life-Saving Antibiotic for Carbapenemase-Producing Enterobacterales

Opioid Medicine: FDA Updates Prescribing Information and Warnings

Pholcodine withdrawn – ALPHO case-control study

Opioids No Better than Placebos in Mitigating Mid-40s Lower Back Pain, Study Finds

Deucravacitinib (Sotyktu): First-In-Class, Allosteric Tyrosine Kinase 2 (Tyk2) Inhibitor For Adults With Moderate-To-Severe Plaque Psoriasis Approved

Singapore Withdraws Popular Cough Medicine Due To Health Risks

FDA Approves Omisirge Cell Therapy to Reduce Infection Risk in Patients with Hematologic Malignancies

Beware: FDA Warns Against Non-Branded Alternatives of Ozempic and Wegovy

Case Study: Filipino on Doxorubicin and Cyclophosphamide Experienced Disturbed Consciousness

Grateful, But Still Not Free From Haemophilia

How an Automated 3D Breast Ultrasound System Is Changing Imaging Workflows

Prof Poh Kian Keong is Singapore’s Only Recipient of the American College of Cardiology’s 2026 Distinguished Awards

Can You Survive a Week on Instant Noodles Alone?

Subscribe to Updates

What's Hot

Browsing: Medication & Drugs

Subscribe to Updates